“Differential distribution of distinct forms of myeloperoxidase in different azurophilic granule subpopulations from human neutrophils”. 《Biochemical and Biophysical Research Communications》 114 (1): 296–303. Jul 1983. doi:10.1016/0006-291x(83)91627-3. PMID6192815.
Davey, Curt; Fenna, Roger (1996). “2.3 Å resolution X-ray crystal structure of the bisubstrate analogue inhibitor salicylhydroxamic acid bound to human myeloperoxidase: a model for a prereaction complex with hydrogen peroxide”. 《Biochemistry》 1996 (35): 10967–10973. doi:10.1021/bi960577m. PMID8718890.
“Mutations affecting the calcium-binding site of myeloperoxidase and lactoperoxidase”. 《Biochemical and Biophysical Research Communications》 281 (4): 1024–9. Mar 2001. doi:10.1006/bbrc.2001.4448. PMID11237766.
“Consequences of total and subtotal myeloperoxidase deficiency: risk or benefit ?”. 《Acta Haematologica》 104 (1): 10–5. 2000. doi:10.1159/000041062. PMID11111115.
“Association between myeloperoxidase levels and risk of coronary artery disease”. 《JAMA》 286 (17): 2136–42. Nov 2001. doi:10.1001/jama.286.17.2136. PMID11694155.
“Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography”. 《Journal of the American College of Cardiology》 55 (11): 1102–9. Mar 2010. doi:10.1016/j.jacc.2009.11.050. PMID20223364.
“Current and emerging techniques for ANCA detection in vasculitis”. 《Nature Reviews. Rheumatology》 10 (8): 494–501. Aug 2014. doi:10.1038/nrrheum.2014.78. PMID24890776.
“Differential distribution of distinct forms of myeloperoxidase in different azurophilic granule subpopulations from human neutrophils”. 《Biochemical and Biophysical Research Communications》 114 (1): 296–303. Jul 1983. doi:10.1016/0006-291x(83)91627-3. PMID6192815.
Davey, Curt; Fenna, Roger (1996). “2.3 Å resolution X-ray crystal structure of the bisubstrate analogue inhibitor salicylhydroxamic acid bound to human myeloperoxidase: a model for a prereaction complex with hydrogen peroxide”. 《Biochemistry》 1996 (35): 10967–10973. doi:10.1021/bi960577m. PMID8718890.
“Mutations affecting the calcium-binding site of myeloperoxidase and lactoperoxidase”. 《Biochemical and Biophysical Research Communications》 281 (4): 1024–9. Mar 2001. doi:10.1006/bbrc.2001.4448. PMID11237766.
“Consequences of total and subtotal myeloperoxidase deficiency: risk or benefit ?”. 《Acta Haematologica》 104 (1): 10–5. 2000. doi:10.1159/000041062. PMID11111115.
“Association between myeloperoxidase levels and risk of coronary artery disease”. 《JAMA》 286 (17): 2136–42. Nov 2001. doi:10.1001/jama.286.17.2136. PMID11694155.
“Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography”. 《Journal of the American College of Cardiology》 55 (11): 1102–9. Mar 2010. doi:10.1016/j.jacc.2009.11.050. PMID20223364.
“Current and emerging techniques for ANCA detection in vasculitis”. 《Nature Reviews. Rheumatology》 10 (8): 494–501. Aug 2014. doi:10.1038/nrrheum.2014.78. PMID24890776.
